|
New Lymphoma Study Findings Recently Were Reported by Researchers at …
HispanicBusiness.com Twenty-four patients were enrolled prospectively and were treated with unlabeled rituximab 70 mg and a therapeutic activity (median 7.3 GBq) of I-131 –rituximab.” The news correspondents obtained a quote from the research from the Institute of … |
Studies from University of Pisa Reveal New Findings on LymphomaHispanicBusiness.comAmong different possible chemotherapeutic approaches, purine analogs, alone or in association with Rituximab, seem to be a valid therapeutic choice. Fifty SMZL patients …
|
Researchers at Department of Haematology and Oncology Report Findings in …
HispanicBusiness.com Their experience showed that this drug is effective and manageable even when reused in both settings: chronic lymphocytic leukemia and non-Hodgkin’s lymphomas combined with rituximab and/or mitoxantrone. The slow evolution in the treatment of patients … |
FDA Product Safety NewsSCVNEWS.comMore informationDrug Safety Communication: Boxed Warning and new recommendations to decrease risk of hepatitis B reactivation with the immune-suppressing and anti-cancer drugs Arzerra (ofatumumab) and Rituxan (rituxima…
|
Studies from West Virginia University Have Provided New Information about …
HispanicBusiness.com The news reporters obtained a quote from the research from West Virginia University , “Randomized trials comparing the addition (or not) of rituximab to high-dose therapy regimens are lacking. No benefit of standard-dose radio-immunotherapy-based … |
Warnings for Hepatitis B Reactivation in Cancer Patients Welcomed by the …Sacramento Bee30, 2013 /PRNewswire/ — Food and Drug Administration (FDA) announced the requirement of a Boxed Warning for the anti-cancer immunosuppressive drugs Arzerra (ofat…
The Emerging Role of Autoimmunity in Myalgic Encephalomyelitis/Chronic …ProHealth… stemming from elevated mitochondrial membrane hyperpolarization and blockade of the methionine cycle with subsequent hypomethylation of DNA. Here we also outline opt…
Warnings for Hepatitis B Reactivation in Cancer Patients Welcomed by the …PR Newswire (press release)Share with Repost.us. ALEXANDRIA, Va., Sept. 30, 2013 /PRNewswire/ — Food and Drug Administration (FDA) announced the requirement of a Boxed Warning…
|
Limbic Encephalitis: The Emperor Really Has New Clothes
Psychiatric News Once diagnosed, the treatment involves immunotherapy—intravenous immunoglobulins, high-dose corticosteroids, plasma exchange, rituximab, azathioprine, and cyclophosphamide deployed sequentially or in parallel. At the same time, a whole-body search … |
|
These 2 Breast Cancer Treatment Makers Will Rise as Another Falls
Motley Fool In addition, Roche and Halozyme’s MabThera SC — a subcutaneous version of Roche’s cancer and arthritis drug rituximab — is under regulatory review in the EU. Another failure at Eli Lilly As Roche and Halozyme shareholders celebrated, shares of Eli … |